Safdar N, Andes D, Craig WA: In vivo pharmacodynamic activity of daptomycin. Antimicrob Agents Chemother 48: 63-68, 2004
Hayden MK, Rezai K, Hayes RA, et al: Development of Daptomycin resistance in vivo in methicillin-resistant Staphylococcus aureus. J Clin Microbiol 43: 5285-5287, 2005
Sharma M, Riederer K, Chase P, et al: High rate of decreasing daptomycin susceptibility during the treatment of persistent Staphylococcus aurcus bacteremia. Eur J Clin Microbiol Infect Dis 27: 433-437, 2008
Patel JB, Jevitt LA, Hageman J, et al: An association between reduced susceptibility to daptomycin and reduced susceptibility to vancomycin in Staphylococcus aureus. Clin Infect Dis 42: 1652-1653, 2006
Arbeit RD, Maki D, Tally FP, et al: The safety and efficacy of daptomycin for the treatment of complicated skin and skin-structure infections. Clin Infect Dis 38: 1673-1681, 2004